The Revival of eConsent

The Revival of eConsent
December 15, 2022 YPrime

The clinical research industry has been reluctant to adopt electronic informed consent (eConsent) for several reasons, not least of which included having to disrupt already stressed and short-staffed work environments to implement new technology. COVID-19 proved to be an inflection point, however, for the industry to continue exploring and implementing digital technologies.

Fortunately, the eClinical technology industry has benefitted by implementing design techniques and user-centric approaches gleaned from consumer-oriented industries to overcome historic objections.

In this webinar, our experts will talk about the value of eConsent, why the industry has been hesitant to adopt it, factors that are driving the reexamination of this technology solution, and new approaches and features that may help the industry reconsider its value.

Watch the webinar to learn more.

WEBINAR

The Revival of eConsent

Michael Hughes and Ian Greenfield

RELATED CONTENT

Getting Better Together Initiative eCOA Lexicon

Getting Better Together Initiative eCOA Lexicon

How to Get the Most Out of Your eCOA Data

How to Get the Most Out of Your eCOA Data

Is BYOD right for your  eCOA Clinical Trial?

Is BYOD right for your eCOA Clinical Trial?

LATEST CONTENT

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Improving DCT Technologies for Efficient and Personalized Delivery

Improving DCT Technologies for Efficient and Personalized Delivery

The Importance of IRT in the Decentralized Clinical Trial Landscape

The Importance of IRT in the Decentralized Clinical Trial Landscape